A step forward for Plasmodium falciparum malaria transmission-blocking vaccines.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
    • Publication Information:
      Original Publication: New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-
    • Subject Terms:
      Malaria, Falciparum*/prevention & control ; Vaccines* ; Malaria Vaccines*; Humans ; Plasmodium falciparum ; Protozoan Proteins ; Antibodies, Protozoan
    • Abstract:
      Competing Interests: We declare no competing interests.
    • Comments:
      Comment on: Lancet Infect Dis. 2023 Nov;23(11):1266-1279. (PMID: 37499679)
    • Accession Number:
      0 (Vaccines)
      0 (Malaria Vaccines)
      0 (Protozoan Proteins)
      0 (Antibodies, Protozoan)
    • Publication Date:
      Date Created: 20230727 Date Completed: 20231030 Latest Revision: 20231031
    • Publication Date:
      20231215
    • Accession Number:
      10.1016/S1473-3099(23)00288-8
    • Accession Number:
      37499677